Cross Country Healthcare Enters Material Agreement, Discloses Regulation FD Information

Cross Country Healthcare Inc. (CCRN) filed a Form 8-K with the SEC on May 7, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01 and exhibits under Item 9.01.

The filing affects Cross Country Healthcare, a provider of healthcare staffing and workforce solutions listed on Nasdaq under ticker CCRN with CIK 0001141103. The company’s most recent public float and revenue scale are not restated in the 8-K; the document focuses on the new agreement and attached exhibits rather than aggregate dollar totals or headcount impacted.

Prior to the filing the company operated without the newly executed contract in place. The new state is that a material definitive agreement now binds Cross Country Healthcare and the named counterparty. The agreement took effect on or before the May 7, 2026 filing date; no later termination or wind-down date is stated in the Items section.

Item 1.02 is not checked, so no simultaneous termination of a prior contract is reported.

Downstream, the company must retain the executed agreement and make it available to the SEC upon request for at least six years. The Regulation FD disclosure requires that any material nonpublic information shared with analysts or investors in connection with the agreement be simultaneously or promptly disseminated to the public.

If the agreement involves financing or a partnership that meets separate SEC thresholds, Cross Country Healthcare will be required to file additional Forms 8-K or amend current reports within four business days of any subsequent triggering events such as closing, funding draw, or covenant default.

Standard Exhibit 10.1 or 99.1 attachments now become part of the permanent SEC record and can be incorporated by reference into future registration statements.

This 8-K constitutes the original public record of the transaction. The filing follows standard practice for public companies to announce material contracts outside the quarterly 10-Q or 10-K cycle. No prior 8-K for the same counterparty appears in the immediate preceding record for this specific agreement.